The common standard for tau-PET assessment is intensity normalization to an inferior cerebellar grey matter (GM) reference, which has been developed for assessment of tau pathology in AD, where the cerebellum typically shows little to no tau pathology [30, 31]. Here, MAPT is linked to Alzheimer disease.